Search

Search Constraints

You searched for: Author/Creator Chen, Danny

Search Results

1. [O2–09–05]: SAFETY, TOLERABILITY, AND PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS OF PF‐06751979, A POTENT AND SELECTIVE ORAL BACE1 INHIBITOR: RESULTS FROM PHASE1 SINGLE AND MULTIPLE ASCENDING DOSE STUDIES IN HEALTHY YOUNG AND OLDER VOLUNTEERS. (1st July 2017)

2. [P4–014]: THE COALITION AGAINST MAJOR DISEASES: TOWARD U.S. FDA QUALIFICATION OF HIPPOCAMPAL VOLUME AS A BIOMARKER FOR ENRICHMENT IN CLINICAL TRIALS FOR PRE‐DEMENTIA STAGES OF ALZHEIMER'S DISEASE. (1st July 2017)

3. A Quality Improvement Initiative to Decrease Central Line–Associated Bloodstream Infections During the COVID-19 Pandemic: A "Zero Harm" Approach. Issue 3 (24th April 2023)

7. Elucidation of the biochemical basis for a clinical drug–drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778 875), a subtype selective agonist of the peroxisome proliferator-activated receptor alpha. (November 2013)

9. Hippocampal Neuroimaging‐Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open Data. Issue 4 (7th March 2020)